Newborn Screening for Cystic Fibrosis, 2nd Edition, NBS05Ed2E
standard by Clinical and Laboratory Standards Institute, 12/01/2019
Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline, Second Edition, A43-A2
standard by Clinical and Laboratory Standards Institute, 04/01/2007
Development and Use of Quality Indicators for Process Improvement and Monitoring of Laboratory Quality; Approved Guideline, QMS12AE
standard by Clinical and Laboratory Standards Institute, 12/01/2010
Quality Management for Molecular Genetic Testing; Approved Guideline, MM20AE
standard by Clinical and Laboratory Standards Institute, 11/01/2012
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
standard by Clinical and Laboratory Standards Institute, 04/25/2016
Reference and Selected Procedures for the Quantitative Determination of Hemoglobin in Blood; Approved Standard, H15-A3
standard by Clinical and Laboratory Standards Institute, 12/01/2000
Principles and Procedures for Detection of Fungi in Clinical Specimens – Direct Examination and Culture; Approved Guideline, M54A
standard by Clinical and Laboratory Standards Institute, 10/01/2012
Nucleic Acid Amplification Assays for Molecular Hematopathology; Approved Guideline-Second Edition,MM05A2E
standard by Clinical and Laboratory Standards Institute, 03/01/2012
Newborn Screening for Hemoglobinopathies, 1st Edition, NBS08Ed1E
standard by Clinical and Laboratory Standards Institute, 10/28/2019
Quality Management System: Leadership and Management Roles and Responsibilities; Approved Guideling, QMS14AE
standard by Clinical and Laboratory Standards Institute, 12/01/2012
One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline – Second Edition., H47-A2
standard by Clinical and Laboratory Standards Institute, 01/01/2008